日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Astroimmunology: the effects of spaceflight and its associated stressors on the immune system

太空免疫学:太空飞行及其相关应激因素对免疫系统的影响

Winer, Daniel A; Du, Huixun; Kim, JangKeun; Chang, Veronica; Burke, Marissa; Winer, Shawn; Costes, Sylvain V; Frippiat, Jean-Pol; Sams, Clarence; Paul, Amber M; Wu, Honglu; Ullrich, Oliver; Baatout, Sarah; Beheshti, Afshin; Mason, Christopher E; Choukér, Alexander; Crucian, Brian E

Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

糖皮质激素通过抑制H4K12乳酸化作用,提高透明细胞肾细胞癌对HIF-2α抑制剂的敏感性。

Zhang, Kenan; He, Lin; Wang, Yizhou; Qin, Sen; Yu, Chunyu; Zheng, Enrun; Zhang, Zedan; Xu, Yawei; Chen, Xiaolin; Liu, Yanhua; Liu, Xiaoya; Guan, Sudun; Xia, Lu; Suo, Feiya; Pei, Fei; Du, Juan; Su, Yiran; Li, Yanze; Wu, Yu; Zhou, Xuehong; Zhou, Jingcheng; Cai, Lin; Tang, Xinjing; Zhang, Zheng; Shang, Yongfeng; Zhang, Qing; Gong, Kan; Sun, Luyang

Antiviral drug discovery and development: challenges and future directions

抗病毒药物的发现与开发:挑战与未来方向

Du, Shaoqing; Hu, Xueping; Li, Ping; Xu, Shujing; Kim, Meehyein; Liu, Xinyong; Zhan, Peng

Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials

IX因子-Padua AAV基因疗法治疗B型血友病:1/2期和3期试验

Xue, Feng; Ju, Mankai; Zhu, Tienan; Zhou, Zeping; Sun, Jing; Yang, Linhua; Yan, Zhenyu; Zhou, Hu; Du, Xin; Zheng, ChangCheng; Zheng, Jing; Wu, Xia; Du, Zengmin; Jiang, Wei; Yang, Caifeng; Xiao, Xiao; Liu, Wei; Yang, Renchi; Zhang, Lei

CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis.

CLCC1 控制内质网双层膜平衡,以维持脂质稳态。

Wu Lingzhi, Wang Jianqin, Wang Yawei, Yang Junhan, Yao Yuanhang, Wang Yonglun, Huang Dong, Hu Yating, Xu Xinxuan, Wang Renqian, Du Wenjing, Shi Yiting, Li Quan, Liu Lu, Zhu Yuangang, Li Shijie, Chen Feng-Jung, Zhang Xiuqin, Wang Xiao, Guo Qiang, Xu Li, Li Peng, Chen Xiao-Wei

The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.

泛素连接酶 KLHL6 驱动对 CD8(+) T 细胞功能障碍的抵抗力。

Cheng Hongcheng, Su Yapeng, Pan Xiaoli, Xu Yue, Xie Ermei, Du Jing, Chen Daniel G, Dai Xiaomeng, Gottardo Raphael, Greenberg Philip D, Li Guideng

Microbiome-produced nicotinic acid controls colon regional identity and injury susceptibility.

微生物群产生的烟酸控制结肠区域特性和损伤易感性。

Rispal Jérémie, Garcia Jasmine R, Palikuqi Brisa, Vegesna Manasa, Vaka Dedeepya, Kang Seung Woo, Trentesaux Coralie, Du Juan, Realini Nicola R, Spencer Paige N, Gardner James M, Hausmann Annika, Kattah Michael G, Lau Ken S, Boffelli Dario, Klein Ophir D

Retraction Note: Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis

撤稿声明:环状RNA circDCUN1D4通过靶向miR-590-5p/TIMP3轴抑制肝细胞癌的发生发展。

Li, Hongyu; Su, Bing; Jiang, Yan; Zhang, Boyang; Du, Rulong; Song, Can; Hou, Bin; Xu, Kun; Wu, Lida; Gu, Yuchun

DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.

DCLK1 通过去泛素化 HDAC6 来驱动膀胱癌的恶性进展和化疗耐药性。

Du Ashuai, Zhou Yuzheng, Deng Xinpei, Yuan Dongbo, Li Kai, Luo Yuanyuan, Tan Songsong, Dai Xuchao, Yu Bo, Jiang Kehua, Tan Xingliang, Zhu Jianguo